The Role of Glucocorticoids in the Treatment of Multisystem Inflammatory Syndrome (MIS-C)—Data from POLISH MIS-C Registry
Background: Multisystem inflammatory syndrome (MIS-C) is a condition related to COVID-19. It’s most significant feature is cardiac involvement. Methods: We have analyzed data from 42 hospitals in the Polish MIS-C Registry. To compare the effect of GCS on fever, we formed two groups: the first treate...
Main Authors: | Ewelina Gowin, Kacper Toczyłowski, Artur Sulik, Jacek Wysocki, Danuta Januszkiewicz-Lewandowska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Children |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9067/9/2/178 |
Similar Items
-
The Youngest Palestinian Case of Multisystem Inflammatory Syndrome in children (MIS-C)
by: Fawzy Mazen Abunejma, et al.
Published: (2022-12-01) -
Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in Switzerland
by: Luregn J. Schlapbach, et al.
Published: (2021-05-01) -
Multisystem Inflammatory Syndrome in Children (MIS-C) with COVID-19: Insights from simultaneous familial Kawasaki Disease cases
by: R. Ebina-Shibuya, et al.
Published: (2020-08-01) -
Multisystem inflammatory syndrome in children (MIS-C) and “Near MIS-C”: A continuum?
by: Sarah Khafaja, et al.
Published: (2023-01-01) -
Similarities and Differences between Multisystem Inflammatory Syndrome in Children (MIS-C) and Kawasaki Disease Shock Syndrome
by: Jin Lee, et al.
Published: (2023-09-01)